Lv3
340 积分 2025-05-22 加入
TROP-2 directed antibody-drug conjugates (ADCs): The revolution of smart drug delivery in advanced non-small cell lung cancer (NSCLC)
25天前
已完结
Sacituzumab govitecan, a novel, third-generation, antibody-drug conjugate (ADC) for cancer therapy
26天前
已完结
PR062/#686 First-in-human phase 1 study of torl-1–23, a novel claudin 6 (CLDN6) targeted antibody drug conjugate (ADC) in patients with ovarian cancer
27天前
已关闭
Upregulation of Trop-2 quantitatively stimulates human cancer growth
1个月前
已完结
Transcriptomic analysis of human Castration-Resistant prostate cancer: insights into novel therapeutic strategies
1个月前
已完结
Bioconjugation with Maleimides: A Useful Tool for Chemical Biology
1个月前
已完结
Receptor CDCP1 is a potential target for personalized imaging and treatment of poor outcome HER2+, triple negative and metastatic ER+/HER2- breast cancers
1个月前
已完结
DE‐310, a novel macromolecular carrier system for the camptothecin analog DX‐8951f: Potent antitumor activities in various murine tumor models
1个月前
已完结
Quantitative acid hydrolysis of DE-310, a macromolecular carrier system for the camptothecin analog DX-8951f
1个月前
已完结
Discovery of the Potent and Selective ATR Inhibitor Camonsertib (RP-3500)
1个月前
已完结
皖公网安备34019202002308
